SS-31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury

SS-31, a novel mitochondria-targeted peptide, has been proven to provide neuroprotection in a variety of neurological diseases. Its role as a mitochondrial reactive oxygen species (ROS) scavenger and the underlying pathophysiological mechanisms in traumatic brain injury (TBI) are still not well understood. The aim of the designed study was to investigate the potential neuroprotective effects of SS-31 and fulfill our understanding of the process of the mitochondrial change in the modified Marmarou weight-drop model of TBI. Mice were randomly divided into sham, TBI, TBI + vehicle, and TBI + SS-31 groups in this study. Peptide SS-31 (5 mg/kg) or vehicle was intraperitoneally administrated 30 min after TBI with brain samples harvested 24 h later for further analysis. SS-31 treatment significantly reversed mitochondrial dysfunction and ameliorated secondary brain injury caused by TBI. SS-31 can directly decrease the ROS content, restore the activity of superoxide dismutase (SOD), and decrease the level of malondialdehyde (MDA) and the release of cytochrome c, thus attenuating neurological deficits, brain water content, DNA damage, and neural apoptosis. Moreover, SS-31 restored the expression of SIRT1 and upregulated the nuclear translocation of PGC-1α, which were proved by Western blot and immunohistochemistry. Taken together, these data demonstrate that SS-31 improves the mitochondrial function and provides neuroprotection in mice after TBI potentially through enhanced mitochondrial rebiogenesis. The present study gives us an implication for further clinical research.

• Publication year

  2018

• Venue

  Oxidative Medicine and Cellular Longevity

• Publication date

  2018-08-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2018/4783602PMID 30224944PMCID 6129854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotection by quercetin via mitochondrial function adaptation in traumatic brain injury: PGC‐1α pathway as a potential mechanism

  2017cited by this paper
• Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury

  2017cited by this paper
• The far-reaching scope of neuroinflammation after traumatic brain injury

  2017cited by this paper
• Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia

  2017cited by this paper
• Ursolic Acid Ameliorates Early Brain Injury After Experimental Traumatic Brain Injury in Mice by Activating the Nrf2 Pathway

  2017cited by this paper
• Mitochondria Targeted Peptide Attenuates Mitochondrial Dysfunction, Controls Inflammation and Protects Against Spinal Cord Injury-Induced Lung Injury

  2017cited by this paper
• Haptoglobin increases the vulnerability of CD163‐expressing neurons to hemoglobin

  2016cited by this paper
• Mitochondrial specific therapeutic targets following brain injury.

  2016cited by this paper
• BAX-induced apoptosis can be initiated through a conformational selection mechanism.

  2015cited by this paper
• Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy

  2015cited by this paper
• Targeting CD36‐Mediated Inflammation Reduces Acute Brain Injury in Transient, but not Permanent, Ischemic Stroke

  2015cited by this paper
• Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

  2014cited by this paper
• Interactions of Oxidative Stress and Neurovascular Inflammation in the Pathogenesis of Traumatic Brain Injury

  2014cited by this paper
• Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway.

  2014cited by this paper
• Perspectives of drug-based neuroprotection targeting mitochondria.

  2014cited by this paper
• Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis.

  2013cited by this paper
• Long-term disability and survival in traumatic brain injury: results from the National Institute on Disability and Rehabilitation Research Model Systems.

  2013cited by this paper
• Traumatic brain injury: oxidative stress and neuroprotection.

  2013cited by this paper
• Changing patterns in the epidemiology of traumatic brain injury

  2013cited by this paper
• Effect of leukotriene inhibitors on evolution of experimental brain contusions

  2012cited by this paper
• Post-Injury Administration of the Mitochondrial Permeability Transition Pore Inhibitor, NIM811, Is Neuroprotective and Improves Cognition after Traumatic Brain Injury in Rats

  2011cited by this paper
• Role of Bcl-2 family proteins and caspases in the regulation of apoptosis

  2011cited by this paper
• Brain Iron Quantification in Mild Traumatic Brain Injury: A Magnetic Field Correlation Study

  2011cited by this paper
• Mitochondrial ATP synthase: architecture, function and pathology

  2011cited by this paper
• Roles of Oxidative Stress, Apoptosis, PGC-1α and Mitochondrial Biogenesis in Cerebral Ischemia

  2011cited by this paper
• Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke.

  2010influential reference
• Predicting Outcomes of Traumatic Brain Injury by Imaging Modality and Injury Distribution

  2009cited by this paper
• Mouse closed head injury model induced by a weight-drop device

  2009cited by this paper
• Transcriptional paradigms in mammalian mitochondrial biogenesis and function.

  2008cited by this paper
• Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury

  2008cited by this paper
• Pathophysiology of traumatic brain injury.

  2007cited by this paper
• Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.

  2006cited by this paper
• Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

  2006cited by this paper
• Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

  2006cited by this paper
• PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.

  2006cited by this paper
• Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases.

  2002cited by this paper
• The Relationship between Intracellular Free Iron and Cell Injury in Cultured Neurons, Astrocytes, and Oligodendrocytes

  2002cited by this paper
• Apaf1 is required for mitochondrial pathways of apoptosis and brain development.

  1998cited by this paper
• Oxidative damage to DNA in diabetes mellitus.

  1996cited by this paper
• Organotropic formation and disappearance of 8-hydroxydeoxyguanosine in the kidney of Sprague-Dawley rats exposed to adriamycin and KBrO3.

  1993cited by this paper
• Basic principles of tissue oxygen determination from mitochondrial signals.

  1973cited by this paper

• Microglial Autophagy and Mitophagy in Ischemic Stroke: From Dual Roles to Therapeutic Modulation

  2025cites this paper
• Szeto-Schiller 31 eases acute lung injury in neonatal mice with acute respiratory distress syndrome by mediating TXNIP expression and NLRP3 inflammasome activation

  2025cites this paper
• Mitochondria-Targeted SS31-Conjugated Liposome Attenuates Oxidative Stress in Endothelial and Skeletal Muscle Cells

  2025cites this paper
• Mitochondria-Targeted Nanoparticles and their Progress in the Treatment of Cerebral Ischaemia-Reperfusion Injury

  2025cites this paper
• Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury

  2025cites this paper
• The Mitochondria‐Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic Age

  2025cites this paper
• Nanomedicines for the treatment of ischemic stroke: an overview of recent advances

  2025cites this paper
• Nasal Inflammation and Brain Bioenergetics: Does Chronic Rhinosinusitis Accelerate Neurodegeneration?

  2025cites this paper
• Cardiolipin and mitochondrial membrane integrity in neurodegeneration: insights from α-synuclein-driven Parkinson’s disease

  2025cites this paper
• Neuron–Glia Crosstalk in the Regulation of Astrocytic Antioxidative Mechanisms Following CNS Injury

  2025cites this paper
• Advancements in Mitochondrial-Targeted Antioxidants: Organelle-Specific Drug Delivery for Disease Management

  2025cites this paper
• Recent advances in theranostic nanomaterials for overcoming traumatic brain injury

  2025cites this paper
• Application Research of Novel Peptide Mitochondrial-Targeted Antioxidant SS-31 in mitigating Mitochondrial Dysfunction.

  2024cites this paper
• The Role of Cardiolipin in Brain Bioenergetics, Neuroinflammation, and Neurodegeneration

  2024cites this paper
• Safeguarding the brain from oxidative damage.

  2024cites this paper
• The mitochondrial-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic age

  2024cites this paper
• Daidzein ameliorates experimental traumatic brain injury‐induced neurological symptoms by suppressing oxidative stress and apoptosis

  2024cites this paper
• The Bioenergetics of Traumatic Brain Injury and its Long-Term Impact for Brain Plasticity and Function.

  2024cites this paper
• Targeting mitochondrial quality control: new therapeutic strategies for major diseases

  2024cites this paper
• Nanozymes targeting mitochondrial repair in disease treatment.

  2024cites this paper
• Microglia-induced neuroinflammation in hippocampal neurogenesis following traumatic brain injury

  2024cites this paper
• From spreading depolarization to blood–brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

  2024cites this paper
• Mitochondrial antioxidant elamipretide improves learning and memory impairment induced by chronic sleep deprivation in mice

  2024cites this paper
• Hypidone hydrochloride (YL-0919) ameliorates functional deficits after traumatic brain injury in mice by activating the sigma-1 receptor for antioxidation

  2024cites this paper
• SS-31 inhibits the inflammatory response by increasing ATG5 and promoting autophagy in lipopolysaccharide-stimulated HepG2 cells.

  2024cites this paper
• Mitochondria-targeting peptide SS-31 attenuates ferroptosis via inhibition of the p38 MAPK signaling pathway in the hippocampus of epileptic rats.

  2024cites this paper
• Neuroprotective mechanisms of OXCT1 via the SIRT3-SOD2 pathway after traumatic brain injury.

  2023cites this paper
• Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury

  2023cites this paper
• SS-31 alleviated nociceptive responses and restored mitochondrial function in a headache mouse model via Sirt3/Pgc-1α positive feedback loop

  2023cites this paper
• A Triple-Targeted Rutin-Based Self-Assembled Delivery Vector for Treating Ischemic Stroke by Vascular Normalization and Anti-Inflammation via ACE2/Ang1-7 Signaling

  2023cites this paper
• Antioxidant peptides, the guardian of life from oxidative stress

  2023cites this paper
• Carvacrol decreases blood–brain barrier permeability post-diffuse traumatic brain injury in rats

  2023cites this paper
• Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases

  2023cites this paper
• Therapeutic targeting of microglia mediated oxidative stress after neurotrauma

  2022influential citation
• Oxidative stress and mitochondrial dysfunction following traumatic brain injury: From mechanistic view to targeted therapeutic opportunities

  2022cites this paper
• Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets.

  2022cites this paper
• In situ forming and biocompatible hyaluronic acid hydrogel with reactive oxygen species-scavenging activity to improve traumatic brain injury repair by suppressing oxidative stress and neuroinflammation

  2022cites this paper
• SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease

  2022cites this paper
• Adiponectin/AdiopR1 signaling prevents mitochondrial dysfunction and oxidative injury after traumatic brain injury in a SIRT3 dependent manner

  2022cites this paper
• Inhibitors of Mitochondrial Dynamics Mediated by Dynamin-Related Protein 1 in Pulmonary Arterial Hypertension

  2022cites this paper
• A Water‐Soluble Quercetin Conjugate with Triple Targeting Exerts Neuron‐Protective Effect on Cerebral Ischemia by Mitophagy Activation

  2022cites this paper
• Antioxidant-based neuroprotective effect of dimethylsulfoxide against induced traumatic brain injury in a rats model

  2022cites this paper
• SS31 Confers Cerebral Protection by Reversing Mitochondrial Dysfunction in Early Brain Injury Following Subarachnoid Hemorrhage, via the Nrf2- and PGC-1α-Dependent Pathways

  2022influential citation
• Dysfunctional Endoplasmic Reticulum-Mitochondrion Coupling Is Associated with Endoplasmic Reticulum Stress-Induced Apoptosis and Neurological Deficits in a Rodent Model of Severe Head Injury

  2022cites this paper
• Neuroprotective Role of Nutritional Supplementation in Athletes.

  2021cites this paper
• Dysfunctional ER-mitochondrion Crosstalk Leads to Subsequent ER Stress-induced Neuronal Apoptosis and Neurological Deficits in an Experimental Rodent Model of Severe Head Injury

  2021cites this paper
• Irisin Rescues Blood-Brain Barrier Permeability following Traumatic Brain Injury and Contributes to the Neuroprotection of Exercise in Traumatic Brain Injury

  2021cites this paper
• SS-31 efficacy in a mouse model of Friedreich ataxia by upregulation of frataxin expression.

  2021cites this paper
• Mitochondrial-Targeting Antioxidant SS-31 Suppresses Airway Inflammation and Oxidative Stress Induced by Cigarette Smoke

  2021cites this paper
• SS-31 Protects Liver from Ischemia-Reperfusion Injury via Modulating Macrophage Polarization

  2021cites this paper
• Blood-Brain Barrier Dysfunction in the Detrimental Brain Function

  2021cites this paper
• Protective Effect of Mitochondrially Targeted Peptide Against Oxidant Injury of Cone Photoreceptors Through Preventing Necroptosis Pathway.

  2021cites this paper
• Whether short peptides are good candidates for future neuroprotective therapeutics?

  2021cites this paper
• Cardiolipin, Mitochondria, and Neurological Disease

  2021influential citation
• Antioxidant Therapies in Traumatic Brain Injury

  2020cites this paper
• Mitochondrial damage & lipid signaling in traumatic brain injury.

  2020cites this paper
• NEUROPROTECTIVE EFFECT OF ORGANIC ACIDS DIAMIDES. FOCUS ON CHANGING MITOCHONDRIAL FUNCTION

  2020cites this paper
• Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment

  2020cites this paper
• 20‐HETE synthesis inhibition attenuates traumatic brain injury–induced mitochondrial dysfunction and neuronal apoptosis via the SIRT1/PGC‐1α pathway: A translational study

  2020cites this paper
• Mitochondrial Dysfunction in Traumatic Brain Injury: Management Strategies

  2020cites this paper
• Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.

  2020cites this paper
• The mitochondria-targeted peptide, bendavia, attenuated ischemia/reperfusion-induced stroke damage.

  2020cites this paper
• Ferroptosis-relevant mechanisms and biomarkers for therapeutic interventions in traumatic brain injury.

  2020cites this paper
• The Attenuation of Traumatic Brain Injury via Inhibition of Oxidative Stress and Apoptosis by Tanshinone IIA

  2020cites this paper
• Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

  2020influential citation
• The single intravenous administration of mitochondria-targeted antioxidant SkQR1 after traumatic brain injury attenuates neurological deficit in rats.

  2019cites this paper
• Methylene Blue Reduces Neuronal Apoptosis and Improves Blood-Brain Barrier Integrity After Traumatic Brain Injury

  2019influential citation
• SS-31 reduces inflammation and oxidative stress through the inhibition of Fis1 expression in lipopolysaccharide-stimulated microglia.

  2019cites this paper
• Sirtuin 1 Regulates Mitochondrial Biogenesis and Provides an Endogenous Neuroprotective Mechanism Against Seizure-Induced Neuronal Cell Death in the Hippocampus Following Status Epilepticus

  2019cites this paper
• Potential of Mitochondria-Targeted Antioxidants to Prevent Oxidative Stress in Pancreatic β-cells

  2019cites this paper
• Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury

  2019cites this paper
• Protective effect of the antioxidative peptide SS31 on ionizing radiation-induced hematopoietic system damage in mice.

  2019cites this paper